Carcinogen Hazard Assessment Monographs Program (R01 Clinical Trial Not Allowed)
This grant funds research to systematically review and evaluate evidence on substances that may cause cancer, producing monographs to inform health policy and cancer prevention.
Funder: National Institutes of Health (NIH)
Due Dates: June 30, 2026 (Estimated)
Funding Amounts: Not specified; award ceiling and floor not listed.
Summary: Supports systematic evaluation of scientific evidence on carcinogenic hazards to humans, producing monographs that inform cancer research, policy, and prevention.
Key Information: Forecasted opportunity; dates and details subject to change.
Description
This Notice of Funding Opportunity (NOFO) from the National Cancer Institute (NCI), a part of the NIH, seeks applications to critically and systematically evaluate the scientific evidence regarding carcinogenic hazards to humans. The goal is to identify potential carcinogens, which is vital for guiding cancer research, informing policy and regulation, and supporting cancer prevention and control efforts. The monographs produced through this program will serve as authoritative references for health policy makers, regulators, researchers, and public health professionals aiming to reduce the cancer burden.
